CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
View All Press
